Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 2:08 PM UTC
| NCT Number | NCT03675893 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Cancer |
| Phase | PHASE2 |
| Target Enrollment | 110 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | June 22, 2026 (Jun 22, 2026) |
As of October 16, 2026: Clinical trial NCT03675893 is currently recruiting participants. This phase2 study for endometrial cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03675893 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03675893 was last updated Jun 22, 2026 (June 22, 2026). HelloStudys verifies this status automatically.